Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Forge Resources Intercepts 105 G/T Au in the Payoff Zone at Alotta Project, Yukon (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioNxt Solutions Inc
C.BNXT
Alternate Symbol(s):
BNXTF
Healthcare
Biotechnology
BioNxt Solutions Inc. is a Canada-based bioscience company. The Company focuses on drug delivery platforms, diagnostic screening systems, and active pharmaceutical ingredient development. Its proprietary platforms include sublingual thin films, transdermal patches, oral tablets, and a new targeted chemotherapy platform. The targeted chemotherapy platform is designed to transform the way...
cytotoxic drugs are administered, by delivering active compounds directly into tumor tissue while minimizing exposure to healthy cells. Its product pipeline includes BNT23001, BNT23002, BNT24002, BNT24003, and BNT24004. BNT23001 is a sublingual Cladribine film targeting multiple sclerosis (MS), offering improved bioavailability and patient convenience. BNT23002 is a sublingual Cladribine formulation for myasthenia gravis (MG), addressing the challenges of oral medication in patients with swallowing difficulties. BNT24002 is a sublingual thin film for the treatment of lupus nephritis (LN).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (CSE:BNXT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
Next
•••
Jonathon Brown
X
Post by
Jonathon Brown
on Nov 06, 2025 9:32am
Buzz on the Bullboards: Baytex, Theralase, and Bombardier drive investor buzz this week
Three companies have captured investor attention. Each represents a different sector—energy, biotech, and aerospace—offering unique stories.
read article.
(570)
•••
Pandora
X
Post by
Pandora
on Nov 05, 2025 8:34pm
Tomorrow from the U.S.
Apparently there is news coming out of the Whitehouse tomorrow regarding a new approach to drugs such as Ozempic and Wegovy and Muanjaro. I have no idea what it is all about other than makig them more
...more
Forge Resources Intercepts 105 G/T Au in the Payoff Zone at Alotta Project, Yukon
posted Nov 17, 2025 9:00am by
Forge Resources Corp.
-
|
Forge Resources announces the first gold assay results from the Phase 2 diamond drill program at Alotta, intercepting 105 g/t Au over a core length of 1.25 m. Majority of assays results are still pending ...read more
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 04, 2025 3:05am
New Press Release - BioNxt Reports "Intention to Grant" Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies
VANCOUVER, BC / ACCESS Newswire / November 4, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce that its wholly owned German subsidiary, Vektor Pharma TF GmbH, has received an "Intention to Grant" notification from the European Patent...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 30, 2025 3:06am
New Press Release - BioNxt Reports "Readiness to Grant" Patent Notification from the Eurasian Patent Organization
VANCOUVER, BC / ACCESS Newswire / October 30, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that the Eurasian Patent Organization (EAPO) has issued a...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 23, 2025 5:30am
New Press Release - BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug
NEW YORK, Oct. 23, 2025 /PRNewswire/ -- BioNxt Solutions Inc. (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience company developing next-generation drug delivery technologies, has launched a 15-day dosing optimization study for its lead product BNT23001, a proprietary sublingual Cladribine...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 21, 2025 3:05am
New Press Release - BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study
VANCOUVER, BC / ACCESS Newswire / October 21, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in next-generation drug delivery technologies, is pleased to announce the launch of an important large-mass animal...
read article.
(27)
•••
Skyrocket666
X
Post by
Skyrocket666
on Oct 16, 2025 3:16am
BNXT Builds on Blockbusters
Blockbusters
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 14, 2025 2:54pm
New Press Release - CSE Bulletin: MOC Eligibility Update
Toronto, Ontario--(Newsfile Corp. - October 14, 2025) - The following CSE-Listed symbol will become MOC Eligible as detailed below. Symbol Company Name Effective Date BNXT BioNxt Solutions Inc. Thursday October 16, 2025 CXXI C21 Investments Inc. FRG Forge Resources Corp. NARA...
read article.
(27)
•••
Skyrocket666
X
Post by
Skyrocket666
on Oct 14, 2025 11:21am
BNXT Takeover Speculation
Takeover Speculation
(27)
•••
Skyrocket666
X
Post by
Skyrocket666
on Oct 10, 2025 1:15pm
BNXT video - Curing cancer and helping fatties!
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 09, 2025 7:50pm
New Press Release - BioNxt Solutions Provides Update To Annual General Meeting Matters Due To Canadian Postal Strike And IR Activities
VANCOUVER, BC, BC / ACCESS Newswire / October 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) wishes to advise its shareholders, due to the Canada Post mail strike, of alternative ways to vote their shares for the upcoming annual general meeting of...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 09, 2025 3:05am
New Press Release - BioNxt Completes "Fast-Track" US Track One Patent Filing for Sublingual Delivery of Cladribine for the Treatment of Multiple Sclerosis
VANCOUVER, BC / ACCESS Newswire / October 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in next-generation drug delivery technologies, today announced that it has completed a Track One priority patent filing with...
read article.
(27)
•••
Skyrocket666
X
Post by
Skyrocket666
on Oct 09, 2025 2:43am
BNXT article - Biotech Gem
Biotech Gem
(27)
•••
Skyrocket666
X
Post by
Skyrocket666
on Oct 03, 2025 3:09am
BNXT Pharmaceutical Revolution
Pharmaceutical Revolution
(27)
•••
Skyrocket666
X
Post by
Skyrocket666
on Oct 02, 2025 3:20am
This is BIG! ....Real BIG!
Chemo breakthrough!!!
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 02, 2025 3:05am
New Press Release - BioNxt Reports Update on Targeted Chemotherapy Drug Delivery Platform
VANCOUVER, BC, BC / ACCESS Newswire / October 2, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a development-stage biopharmaceutical company specializing in advanced drug-delivery technologies, is pleased to report a significant advancement regarding...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Silver North Intersects 13.15 m Averaging 818 g/t Silver and 1.39 g/t Gold at the Haldane Property